影響力 1
[Practical application of the captopril challenge test for diagnosing primary aldosteronism].
發表日期: 2026-07-28
Zhonghua yi xue za zhi
Medical Digest 收錄日: 2026-07-29
(Abstract too short for summarization)
在PubMed上閱讀內分泌科5 篇
影響力 1
[The impact of dietary sodium intake on therapeutic efficacy and short-term renal injury in patients after treatment for primary aldosteronism].
發表日期: 2026-07-28
Zhonghua yi xue za zhi
Medical Digest 收錄日: 2026-07-29
(Abstract too short for summarization)
在PubMed上閱讀影響力 1
Dose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes.
發表日期: 2026-07-28
British journal of clinical pharmacology
Medical Digest 收錄日: 2026-07-29
(Summary generation failed. Please refer to the original article.)
在PubMed上閱讀影響力 1
Beyond Siloed Care: The Promise and Challenge of Cardiovascular-Kidney-Metabolic Syndrome.
發表日期: 2026-07-28
Circulation
Medical Digest 收錄日: 2026-07-29
(No abstract provided)
在PubMed上閱讀影響力 2
Visceral adiposity and lipid-related metabolic markers in normal-weight adolescent girls with polycystic ovary syndrome.
發表日期: 2026-07-27
European journal of pediatrics
Medical Digest 收錄日: 2026-07-29
This study found that normal-weight adolescents with polycystic ovary syndrome (PCOS) have greater visceral adiposity compared to healthy controls, even after adjusting for BMI percentile. Triglycerides and the TG/HDL-C ratio were higher in the PCOS group but should be interpreted cautiously in r...
在PubMed上閱讀